GPC3 and liver cancer: Another research on Interleukin-15-armored GPC3-CAR T cells for solid tumors, including liver cancer, showed that IL15 increases the expansion, intratumoral survival, and antitumor activity of GPC3-CAR-T cells in patients (33).